Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial...
Covaxin
Manish Tewari
Krishna Ella
Bharat Biotech
Hyderabad
While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of..
While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of..
